Key Drivers
- Margin Improvement
- Strong Cash Flow
- High Leverage
AIAI Summary
ASTH's thesis has improved from a simple roll-up to a scaled value-based care operator with real operating leverage and stronger cash generation, but the stock still hinges on execution in reimbursement, integration, and cost control as elevated valuation leaves little room for slippage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Improvement
- •Strong Cash Flow
- •High Leverage
ASTH is showing margin and cash-flow improvement, but profitability remains thin, leverage is still meaningful, and the stock looks expensive relative to earnings.
Price Behavior
Key Price Behavior Insights:
- •Sharp rebound
- •Range resistance
- •$38 support
ASTH has bounced sharply from its early-August low, but it is still below last month's downtrend resistance near $41.0–$45.5, making $38 the key near-term hold level for the rebound to continue.
Sharp rebound from the $34.13 low after the early-August selloff
Sentiment & News
Key News Insights:
- •Record EPS
- •Cost Efficiency
- •Full-Risk Shift
Astrana Health posted strong Q2 growth with record EPS, improving margins, and expanding full-risk care exposure, signaling continued operational momentum.
The results and valuation discount suggest the stock may have upside if Astrana sustains growth and execution in its value-based care model
Similar Companies in Healthcare
Other companies in the same sector with AI ratings